Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00237887 · COMPLETED
Trial details
- NCT number
- NCT00237887
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 1212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.